CD274 and chronic myelogenous leukemia, BCR-ABL1 positive: Although the mechanism of action of the ICIs in CML is unclear, it has been demonstrated, in murine models, that the therapeutic effects of PD1/PDL1 blockade may be mediated, at least in part, through a strong NK response [204].